Time

Session

Speaker

Opening Ceremony

07:30-07:40

(5 mins each)

Opening Remarks

Do Joon Park, M.D., Ph.D.

(Director General of KNIH)

Opening Remarks

Michael Gottesman, M.D.

(Deputy Director for Intramural Research, NIH)

Session 1

Precision Medicine on Cancer

Chair:

Kang Hyun Lee, M.D., Ph.D,

(President of NCC)

Michael Gottesman, M.D.

(Deputy Director for Intramural Research, NIH)

07:40-08:20

(20 mins each)

Towards Precision Prevention in Oncology

Stephen Chanock, M.D.

(Division Director of

Cancer Epidemiology & Genetics, NCI)

Precision Medicine for Lung Cancer

Ji-Youn Han, M.D., Ph.D.

(Head of Precision Medicine Branch, NCC)

08:20-08:45

(25 min)

Discussion

Session 2

Precision Medicine on Cohort

Chair:

Do Joon Park, M.D., Ph.D.

(Director General of KNIH)

Michael Gottesman, M.D.

(Deputy Director for Intramural Research, NIH)

08:45-9:45

(20 mins each)

Charting Our Future Together:

Towards Predictive Biology and

Precision Medicine in Heart, Lung, Blood and Sleep Research

Gary Gibbons, M.D.

(Director, NHLBI, NIH)

The Current Status and Prospect of

the KNIH Cohort Project (KOGES)

Sung Soo Kim, Ph.D.

(Division Director of

Epidemiology and Health Index)

Diabetes Epidemiology Cohort Study

Nam Han Cho, M.D., Ph.D.

(President-Elect,

International Diabetes Federation

Prof., Dept. of Preventive Medicine, Ajou Univ.)

09:45-10:10

(25 min)

Discussion

10:10-10:20

(10 min)

Closing Remarks

Time

Session

Speakers

10:30-11:00

Registration

Opening

11:00-11:30

(30 min)

Opening Remark

Do Joon Park, M.D., Ph.D.

(Director General of KNIH)

Kang Hyun Lee, M.D., Ph.D,

(President of NCC)

Welcoming Remark

Ministry of Health and Welfare

Congratulatory Address

Group Photo

Session 1

Policy Direction and Regulation for Promoting PM

11:30-12:00

Korea Precision Medicine Initiative Roadmap

Session 2

Precision Medicine Cohort and Platform

12:00-13:00

(20 mins each)

The Role of Cohort Studies in Precision Medicine Research

Precision Medicine and Mobile Device

Regulation and Technical Issues on Portability and Security of Precision Medicine information

13:00-14:00

Lunch

Session 3

Precision Medicine Platform and Social Acceptance

14:00 -15:00

(20 mins each)

Standardization to Support PMI Platforms

Collaborative Research Platform for Clinical Research

Ethical, Legal and Social Issues and Responses in Precision Medicine and Cohort Research

Session 4

Research on PM for Cancer

15:00-16:00

(20 mins each)

Key Success Factors for Precision Medicine

Precision Medicine for Lung Cancer

Functional Genomics Approach toward Cancer Precision Medicine

16:00-16:10

Coffee Break

16:10-17:00

(50 min)

Panel Discussion